Breaking Convention 2017
Featured Research Mithoefer M, Grob C, Brewerton T (2016): Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. The Lancet Psychiatry 3 (5): 481–488 Heifets B, Malenk …
Research
Two New Studies Show Ibogaine’s Promise As Treatment for Opioid Addiction
Observational research published in American Journal of Drug and Alcohol Abuse CONTACT:Brad Burge, Director of Communications and Marketing, MAPSMedia Requests:Press Resources: Ismail Ali, Policy Fellow, …
Therapist Training Study: 25th and 26th Participants Enrolled in Boulder
On March 1 and March 29, 2017, the 25th and 26th participants were enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. The …
Ayahuasca for PTSD: Survey Update (April 2017)
As of March 28, 2017, we have received 327 completed responses for our anonymous questionnaire about the potential risks and benefits associated with using ayahuasca as a therapy for posttraumatic stress …
Survey: Ayahuasca for PTSD
As of February 27, 2017, we have received 310 completed responses for our new anonymous questionnaire about the potential risks and benefits associated with using ayahuasca as a therapy for posttraumatic …
Survey: Ayahuasca for PTSD
As of January 31, 2017, we have received 268 completed responses for our new anonymous questionnaire about the potential risks and benefits associated with using ayahuasca as a therapy for posttraumatic …
Therapist Training Study: 22nd and 23rd Participants Enrolled in Colorado
On January 11 and January 25, 2017, the 22nd and 23rd participants were enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. …
Therapist Training Study: 20th and 21st Participants Enrolled in South Carolina and Colorado
On January 9, 2017, the 16th participant was enrolled at the Charleston, South Carolina study site of our ongoing Phase 1study of the psychological effects of MDMAwhen used in a therapeutic setting by …
Survey: Ayahuasca for PTSD (January 2017)
As of January 6, 2017, we have received 239 completed responses for our new anonymous questionnaire about the potential risks and benefits associated with takingayahuasca as a therapy for posttraumatic …
Survey Update: Ayahuasca for PTSD
As of December 1, 2016, we have received 202 completed responses for our new anonymous questionnaire about the potential risks and benefits associated with taking ayahuasca as a therapy for posttraumatic …
Therapist Training Study: 19th Participant Enrolled
On November 30, 2016, the fourth participant was enrolled at the recently initiated Boulder, Colorado study site in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic …
Survey: Ayahuasca for PTSD
We are currently accepting responses for our new anonymous questionnaire about the potential risks and benefits associated with taking ayahuasca as a therapy for posttraumatic stress disorder (PTSD). The …
